122 related articles for article (PubMed ID: 16518295)
1. [Candesartan Cilexetil (Atacand) induced prolonged severe cholestasis improved by extracorporeal albumin dialysis].
Sturm N; Hilleret MN; Dreyfus T; Barnoud D; Leroy V; Zarski JP
Gastroenterol Clin Biol; 2005 Dec; 29(12):1299-301. PubMed ID: 16518295
[No Abstract] [Full Text] [Related]
2. Concomitant administration of candesartan cilexetil in patients on paclitaxel and carboplatin combination therapy increases risk of severe neutropenia
.
Katsube Y; Hira D; Tsujimoto M; Koide H; Minegaki T; Ikeda Y; Morita SY; Nishiguchi K; Terada T
Int J Clin Pharmacol Ther; 2018 Jul; 56(7):328-336. PubMed ID: 29792394
[TBL] [Abstract][Full Text] [Related]
3. Two- and three-drug therapy with candesartan cilexetil (Atacand) successful in patients with severe hypertension.
Cardiovasc J S Afr; 2005; 16(5):288. PubMed ID: 16307167
[No Abstract] [Full Text] [Related]
4. Candesartan cilexetil-induced severe hepatotoxicity.
Basile G; Villari D; Gangemi S; Ferrara T; Accetta MG; Nicita-Mauro V
J Clin Gastroenterol; 2003 Mar; 36(3):273-5. PubMed ID: 12590242
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of combination therapy with candesartan cilexetil and pioglitazone hydrochloride in patients with hypertension and type 2 diabetes mellitus.
Kaku K; Enya K; Sugiura K; Totsuka N
Curr Med Res Opin; 2011 Nov; 27 Suppl 3():73-84. PubMed ID: 22106979
[TBL] [Abstract][Full Text] [Related]
6. Candesartan cilexetil: comparison of once-daily versus twice-daily administration for systemic hypertension. Candesartan Cilexetil Study Investigators.
Zuschke CA; Keys I; Munger MA; Carr AA; Marinides GN; Flanagan TL; Cushing DJ; Hayes JL; Michelson EL
Clin Ther; 1999 Mar; 21(3):464-74. PubMed ID: 10321416
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
[TBL] [Abstract][Full Text] [Related]
8. Effects of candesartan cilexetil "add-on" treatment in congestive heart failure outpatients in daily practice.
Mitrovic V; Appel KF; Proskynitopoulos N; Dereli S; Hamm CW
Clin Res Cardiol; 2009 Jun; 98(6):379-89. PubMed ID: 19294444
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic properties and bioequivalence of candesartan cilexetil in Korean healthy volunteers.
Jeon JY; Im YJ; Kim Y; Han SM; Jo MJ; Shin DH; Yoo JS; Moon BK; Kim BK; Lee BH; Choi YH; Cho BS; Jang HY; Chae SW; Kim MG
Drug Dev Ind Pharm; 2013 Sep; 39(9):1296-9. PubMed ID: 23030309
[TBL] [Abstract][Full Text] [Related]
10. Effects of candesartan cilexetil in patients with severe systemic hypertension. Candesartan Cilexetil Study Investigators.
Oparil S; Levine JH; Zuschke CA; Gradman AH; Ripley E; Jones DW; Hardison JD; Cushing DJ; Prasad R; Michelson EL
Am J Cardiol; 1999 Aug; 84(3):289-93. PubMed ID: 10496437
[TBL] [Abstract][Full Text] [Related]
11. The effect duration of candesartan cilexetil once daily, in comparison with enalapril once daily, in patients with mild to moderate hypertension.
Himmelmann A; Keinänen-Kiukaanniemi S; Wester A; Redón J; Asmar R; Hedner T;
Blood Press; 2001; 10(1):43-51. PubMed ID: 11332334
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with candesartan cilexetil plus hydrochlorothiazide in patients unresponsive to low-dose hydrochlorothiazide.
Plouin PF
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S65-6. PubMed ID: 9331012
[No Abstract] [Full Text] [Related]
13. Dose-finding study of candesartan cilexetil plus hydrochlorothiazide in patients with mild to moderate hypertension.
Philipp T; Letzel H; Arens HJ
J Hum Hypertens; 1997 Sep; 11 Suppl 2():S67-8. PubMed ID: 9331013
[No Abstract] [Full Text] [Related]
14. Fixed-dose combination therapy of candesartan cilexetil and amlodipine besilate for the treatment of hypertension in Japan.
Yasuno S; Fujimoto A; Nakagawa Y; Kuwahara K; Ueshima K
Expert Rev Cardiovasc Ther; 2012 May; 10(5):577-83. PubMed ID: 22651833
[TBL] [Abstract][Full Text] [Related]
15. Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study Investigators.
Reif M; White WB; Fagan TC; Oparil S; Flanagan TL; Edwards DT; Cushing DJ; Michelson EL
Am J Cardiol; 1998 Oct; 82(8):961-5. PubMed ID: 9794352
[TBL] [Abstract][Full Text] [Related]
16. Erythema multiforme associated with candesartan cilexetil.
Ejaz AA; Walsh JS; Wasiluk A
South Med J; 2004 Jun; 97(6):614-5. PubMed ID: 15255435
[TBL] [Abstract][Full Text] [Related]
17. [Investigations of the antihypertensive long-term action of candesartan cilexetil in different dosages under the influence of therapy-free intervals].
Weisser B; Gerwe M; Braun M; Funken C
Arzneimittelforschung; 2005; 55(9):505-13. PubMed ID: 16229114
[TBL] [Abstract][Full Text] [Related]
18. Effective dose range of candesartan cilexetil for systemic hypertension. Candesartan Cilexetil Study Investigators.
Bell TP; DeQuattro V; Lasseter KC; Ruff D; Hardison JD; Cushing D; Kezer AE; Michelson EL
Am J Cardiol; 1999 Jan; 83(2):272-5, A6. PubMed ID: 10073836
[TBL] [Abstract][Full Text] [Related]
19. Candesartan cilexetil effectively reduces blood pressure in hypertensive children.
Franks AM; O'Brien CE; Stowe CD; Wells TG; Gardner SF
Ann Pharmacother; 2008 Oct; 42(10):1388-95. PubMed ID: 18664605
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of 10-mg azilsartan compared with 8-mg candesartan cilexetil in Japanese patients with hypertension: a randomized crossover non-inferiority trial.
Takahara M; Shiraiwa T; Shindo M; Arai A; Kusuda Y; Katakami N; Kaneto H; Matsuoka TA; Shimomura I
Hypertens Res; 2014 Sep; 37(9):852-7. PubMed ID: 24739538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
